Valuation: CVRx, Inc.

Market Cap 137M 119M 111M 102M 193M 13.11B 196M 1.31B 514M 6.53B 516M 504M 21.88B P/E 2026 *
-2.64x
P/E 2027 * -2.73x
Enterprise Value 163M 142M 132M 121M 228M 15.54B 232M 1.55B 610M 7.74B 612M 598M 25.95B EV / Sales 2026 *
2.49x
EV / Sales 2027 * 2.7x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day-3.81%
1 week+9.18%
1 month-5.91%
3 months-35.07%
6 months-24.45%
Current year-27.11%
1 week 4.75
Extreme 4.75
5.39
1 month 4.64
Extreme 4.64
5.93
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 43 01/10/2020
Chief Operating Officer 57 11/08/2025
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap.
27/2/26 Free

Chief Executive Officer

404,763 1.5443%
27/2/26 Free

Chief Operating Officer

38,000 0.1450%
27/2/26 Free

Executive/Senior Manager

90,964 0.3471%
Change 5-day change 1-year change 3-year change Capi.($)
-3.81%+9.18%-31.55%-71.98% 137M
+0.43%+0.77%+32.17%+7.66% 12.65B
+0.55%+3.08%+25.28%+19.48% 6.78B
-0.80%+6.33%+50.71%+21.80% 5.98B
-0.52%+7.25% - - 5.07B
+3.47%+9.59%-18.67%+44.43% 4.75B
+0.32%+5.56%-19.89%-16.85% 4.15B
+0.32%+5.10%-25.54%+205.94% 1.84B
-2.56%-15.92%+31.10%-54.55% 1.73B
+1.27%-0.82%+53.75%-8.45% 1.58B
Average -0.13%+2.80%+10.82%+16.39% 4.47B
Weighted average by Cap. +0.39%+3.28%+20.16%+19.22%

Financials

2026 *2027 *
Net sales 65.28M 56.75M 52.82M 48.5M 91.59M 6.23B 93M 623M 244M 3.1B 245M 240M 10.4B 76.18M 66.22M 61.64M 56.59M 107M 7.27B 109M 727M 285M 3.62B 286M 280M 12.14B
Net income -52.82M -45.92M -42.74M -39.24M -74.1M -5.04B -75.25M -504M -198M -2.51B -198M -194M -8.42B -52.14M -45.33M -42.19M -38.73M -73.15M -4.98B -74.28M -497M -195M -2.48B -196M -192M -8.31B
Net Debt 25.51M 22.18M 20.64M 18.95M 35.79M 2.44B 36.34M 243M 95.5M 1.21B 95.81M 93.71M 4.07B 68.44M 59.49M 55.38M 50.84M 96.01M 6.53B 97.5M 653M 256M 3.25B 257M 251M 10.91B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
31/07/26 USD 5.175 -3.81% 95,412
30/07/26 USD 5.380 +8.69% 268,691
29/07/26 USD 4.950 -.--% 153,855
28/07/26 USD 4.950 +1.43% 153,586
27/07/26 USD 4.880 +2.95% 248,254
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
5.175USD
Average target price
11.17USD
Spread / Average Target
+115.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock